Avesi Partners-backed Danforth Health acquires rare disease consultancy Ambit
Ambit RD, founded to help biopharma companies navigate commercial challenges in rare and specialty disease markets, brings AI-powered patient identification and analytics tools to Danforth's platform. The post Avesi Partners-backed Danforth Health acquires rare disease consultancy Ambit appeared first on PE Hub .
We haven't written up this one. PE Hub has the full story — the link below goes straight to it.